In suspected pulmonary embolism with shock, what emergent therapy may be considered if there are no contraindications?

• A. Antibiotics
• B. Systemic thrombolysis if no contraindications
• C. Heparin only
• D. Placement of vena cava filter

Answer: (B)

In massive pulmonary embolism with shock, the priority is to rapidly restore pulmonary perfusion and relieve right ventricular strain. Emergent systemic thrombolysis is the best option when there are no contraindications because it dissolves the thrombus quickly, improves hemodynamics, and can reduce mortality in unstable patients.

Thrombolytic therapy uses agents (such as tissue plasminogen activator) to convert plasminogen to plasmin, actively breaking down fibrin and dissolving the clot. This rapid action is crucial in shock where the embolus is acutely obstructing blood flow and the heart cannot maintain adequate output.

Antibiotics have no role here because this scenario is not an infection. Heparin anticoagulation slows clot propagation but does not promptly dissolve the existing embolus, making it insufficient as the sole emergent therapy in the setting of shock. A vena cava filter can prevent further emboli from reaching the lungs but does not acutely treat the current clot burden or stabilize the patient in shock; it is reserved for scenarios where anticoagulation is contraindicated or there are recurrent emboli, not as the immediate lifesaving therapy in unstable PE.

If thrombolysis is contraindicated, other urgent options like surgical embolectomy or catheter-directed therapies may be considered, but when there are no contraindications, systemic thrombolysis offers the fastest potential recovery of hemodynamics.